Cingulate Inc. (CINGW) — 8-K Filings

8-K Filings (40)

• 8-K Filing — Dec 15, 2025
• Cingulate Inc. Files 8-K: Material Agreement and Financials — Nov 10, 2025 Risk: medium
  On November 7, 2025, Cingulate Inc. entered into a material definitive agreement, likely related to financing or a significant business transaction. This also t
• Cingulate Inc. Files 8-K Report — Oct 14, 2025 Risk: low
  On October 14, 2025, Cingulate Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and exh
• Cingulate Inc. Files 8-K on Security Holder Vote — Sep 25, 2025 Risk: low
  Cingulate Inc. filed an 8-K on September 25, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain details about t
• Cingulate Inc. Reports Unregistered Equity Sales — Sep 5, 2025 Risk: medium
  On August 29, 2025, Cingulate Inc. reported unregistered sales of equity securities. The company, headquartered in Kansas City, KS, filed a Form 8-K detailing t
• Cingulate Inc. Files 8-K: Leadership and Compensation Changes — Aug 28, 2025 Risk: medium
  On August 22, 2025, Cingulate Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicates
• Cingulate Inc. Files 8-K on Operations and Financials — Aug 19, 2025 Risk: low
  On August 19, 2025, Cingulate Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial
• Cingulate Inc. Reports Director and Officer Changes — Aug 15, 2025 Risk: medium
  Cingulate Inc. filed an 8-K on August 15, 2025, reporting events as of August 14, 2025. The filing indicates changes related to the departure or election of dir
• Cingulate Inc. Elects New Directors, Updates Executive Compensation — Aug 8, 2025 Risk: medium
  On August 7, 2025, Cingulate Inc. announced changes to its board of directors and executive compensation. Specifically, the company elected two new directors, D
• Cingulate Inc. Files 8-K Report — Aug 6, 2025 Risk: low
  On August 6, 2025, Cingulate Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation
• Cingulate Inc. Reports Director Changes and Officer Appointments — Jun 11, 2025 Risk: medium
  Cingulate Inc. filed an 8-K on June 11, 2025, reporting on several key events that occurred on June 10, 2025. These include the departure and election of direct
• Cingulate Inc. Terminates Material Definitive Agreement — May 13, 2025 Risk: medium
  On May 13, 2025, Cingulate Inc. filed an 8-K report indicating the termination of a material definitive agreement. The filing does not specify the counterparty
• Cingulate Inc. Files 8-K: Material Agreement & Financials — Apr 9, 2025 Risk: medium
  On April 8, 2025, Cingulate Inc. entered into a material definitive agreement. The company also made a Regulation FD disclosure and filed financial statements a
• Cingulate Inc. Files 8-K on Financials — Mar 26, 2025 Risk: low
  On March 26, 2025, Cingulate Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fin
• Cingulate Inc. Files 8-K — Mar 4, 2025 Risk: low
  Cingulate Inc. filed an 8-K on March 4, 2025, reporting on other events and financial statements. The filing does not contain specific details about material ev
• Cingulate Inc. Files 8-K Report — Feb 3, 2025 Risk: low
  On January 28, 2025, Cingulate Inc. filed an 8-K report detailing other events. The company, headquartered in Kansas City, KS, with IRS number 86-3825535, is in
• Cingulate Inc. Files 8-K: Board and Compensation Changes — Jan 24, 2025 Risk: medium
  On January 17, 2025, Cingulate Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indicate
• Cingulate Inc. Files 8-K Report — Jan 7, 2025 Risk: low
  On January 7, 2025, Cingulate Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulatio
• Cingulate Inc. Raises $1.5M via Convertible Notes — Dec 23, 2024 Risk: medium
  On December 20, 2024, Cingulate Inc. entered into a material definitive agreement, specifically a Securities Purchase Agreement, with an accredited investor. Th
• Cingulate Inc. Files 8-K Report — Oct 15, 2024 Risk: medium
  On October 15, 2024, Cingulate Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating update
• Cingulate Inc. Files 8-K: Other Event Reported — Oct 7, 2024 Risk: medium
  Cingulate Inc. filed an 8-K on October 7, 2024, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or dat
• Cingulate Inc. Files 8-K Report — Oct 4, 2024 Risk: low
  On October 4, 2024, Cingulate Inc. filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific financial transactions or sign
• Cingulate Appoints New CMO and CSO, Adds to Board — Sep 12, 2024 Risk: medium
  On September 9, 2024, Cingulate Inc. announced the appointment of Dr. David M. Bear as Chief Medical Officer and Dr. Robert J. T. Miller as Chief Scientific Off
• Cingulate Inc. to be Acquired by Highline Capital Affiliate — Sep 10, 2024 Risk: medium
  Cingulate Inc. announced on September 9, 2024, that it has entered into a definitive agreement to sell its entire issued and outstanding capital stock to an aff
• Cingulate Inc. Files 8-K Report — Sep 3, 2024 Risk: low
  On September 3, 2024, Cingulate Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific fina
• Cingulate Inc. Agrees to Acquisition by Highline Capital Affiliate — Aug 29, 2024 Risk: medium
  Cingulate Inc. announced on August 28, 2024, that it has entered into a definitive agreement to sell its entire issued and outstanding capital stock to an affil
• Cingulate Inc. Files 8-K on Security Holder Votes — Aug 28, 2024 Risk: medium
  Cingulate Inc. filed an 8-K on August 28, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate str
• Cingulate Inc. Files 8-K Report — Aug 19, 2024 Risk: low
  On August 15, 2024, Cingulate Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware with its principal
• Cingulate Inc. Faces Delisting Notice, Corporate Changes — Aug 7, 2024 Risk: high
  Cingulate Inc. filed an 8-K on August 7, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of August 2, 2024. This filing a
• Cingulate Inc. Files 8-K on Security Holder Votes — Jul 30, 2024 Risk: low
  Cingulate Inc. filed an 8-K on July 30, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details abo
• Cingulate Inc. Files 8-K on Equity Sales and Security Holder Rights — Jul 1, 2024 Risk: medium
  On June 28, 2024, Cingulate Inc. entered into a material definitive agreement related to unregistered sales of equity securities. This filing also addresses mat
• Cingulate Inc. Faces Nasdaq Delisting Warning — Jun 18, 2024 Risk: high
  Cingulate Inc. received a notice on June 17, 2024, indicating it failed to meet a continued listing rule or standard for its common stock on the Nasdaq Capital
• Cingulate Inc. Files 8-K: Director Changes, Officer Compensation — Jun 12, 2024 Risk: medium
  Cingulate Inc. filed an 8-K on June 11, 2024, reporting on the departure of a director, the election of new directors, and compensatory arrangements for officer
• Cingulate Inc. Closes $10M Public Offering — May 28, 2024 Risk: medium
  On May 21, 2024, Cingulate Inc. announced the closing of its previously disclosed underwritten public offering. The company successfully raised approximately $1
• Cingulate Inc. Files 8-K Report — May 13, 2024 Risk: medium
  On May 13, 2024, Cingulate Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or new material informati
• Cingulate Inc. Files 8-K Report — Mar 18, 2024 Risk: low
  On March 18, 2024, Cingulate Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware with its principal
• Cingulate Inc. Delisted from Nasdaq, Moves to OTCQB — Feb 26, 2024 Risk: high
  Cingulate Inc. received a delisting notice from Nasdaq on February 22, 2024, due to its common stock and warrants failing to meet the minimum bid price requirem
• Cingulate Inc. Reports Officer and Director Changes — Feb 13, 2024 Risk: medium
  Cingulate Inc. filed an 8-K on February 12, 2024, reporting events related to the departure or election of directors or certain officers, as well as compensator
• Cingulate Enters Material Definitive Agreement on Feb 2 — Feb 7, 2024
  Cingulate Inc. entered into a material definitive agreement on February 2, 2024, regarding its Common Stock, par value $0.0001 per share, and warrants exercisab
• Cingulate Sells 1M Shares & Warrants in Private Placement — Jan 29, 2024
  Cingulate Inc. entered into a definitive agreement on January 25, 2024, for a private placement offering of 1,000,000 shares of common stock and warrants to pur

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX